Suppr超能文献

Oligonucleotide Drugs for Transthyretin Amyloidosis.

作者信息

Buxbaum Joel N

机构信息

Scripps Research Institute, La Jolla, CA

出版信息

N Engl J Med. 2018 Nov 22;379(21):2086. doi: 10.1056/NEJMc1810994.

Abstract
摘要

相似文献

1
Oligonucleotide Drugs for Transthyretin Amyloidosis.
N Engl J Med. 2018 Nov 22;379(21):2086. doi: 10.1056/NEJMc1810994.
2
Oligonucleotide Drugs for Transthyretin Amyloidosis.
N Engl J Med. 2018 Jul 5;379(1):82-85. doi: 10.1056/NEJMe1805499.
3
Oligonucleotide Drugs for Transthyretin Amyloidosis.
N Engl J Med. 2018 Nov 22;379(21):2085-6. doi: 10.1056/NEJMc1810994.
4
Oligonucleotide Drugs for Transthyretin Amyloidosis.
N Engl J Med. 2018 Nov 22;379(21):2086. doi: 10.1056/NEJMc1810994.
5
Inotersen: new promise for the treatment of hereditary transthyretin amyloidosis.
Drug Des Devel Ther. 2019 May 6;13:1515-1525. doi: 10.2147/DDDT.S162913. eCollection 2019.
6
Recent progress in the understanding and treatment of transthyretin amyloidosis.
J Clin Pharm Ther. 2014 Jun;39(3):225-33. doi: 10.1111/jcpt.12145.
7
Inotersen (transthyretin-specific antisense oligonucleotide) for treatment of transthyretin amyloidosis.
Neurodegener Dis Manag. 2019 Feb;9(1):25-30. doi: 10.2217/nmt-2018-0037. Epub 2018 Dec 18.
8
Inotersen for the Treatment of Hereditary Transthyretin Amyloidosis.
Methods Mol Biol. 2020;2176:87-98. doi: 10.1007/978-1-0716-0771-8_6.
10
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis.
N Engl J Med. 2018 Jul 5;379(1):22-31. doi: 10.1056/NEJMoa1716793.

引用本文的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验